Sort
64,565 grants matching “drug discovery”
Geisinger eGenonic Medicine (GeM) Program
$1,063,790David J. Carey · Geisinger Clinic · U01 · FY2013 · HG
Resource for NMR Molecular Imaging of Proteins
$1,063,460Stanley J Opella · University Of California, San Diego · P41 · FY2010 · EB
The UIUC Neuroproteomics Center on Cell-Cell Signaling
$1,063,324Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2009 · DA
Interventional approaches for restoring vision
$1,063,252Anand Swaroop · National Eye Institute · ZIA · FY2017 · EY
Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential
$1,063,004Matthew S. Gentry · University Of Florida · R35 · FY2023 · NS
CENTER FOR COMPUTATIONAL MASS-SPECTROMETRY
$1,062,982Pavel A Pevzner · University Of California, San Diego · P41 · FY2010 · RR
Center for Computational Mass-Spectrometry
$1,062,982Pavel A Pevzner · University Of California, San Diego · P41 · FY2010 · RR
Leadership in AD/ADRD Drug Discovery
$1,062,600Stuart A Lipton · Scripps Research Institute, The · R35 · FY2022 · AG
Leadership in AD/ADRD Drug Discovery
$1,062,600Stuart A Lipton · Scripps Research Institute, The · R35 · FY2021 · AG
Parent Project - Main Theme (MAIN)
$1,062,196Mark J Ratain · University Of Chicago · U01 · FY2010 · GM
Pharmacology & human Phase 1 safety & dose escalation studies using anti-GP88 in aggressive breast cancer
$1,062,115Ginette Serrero · A And G Pharmaceutical, Inc. · R44 · FY2020 · CA
Novel therapeutic development for small cell lung cancer
$1,062,000Charles M Rudin · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Novel therapeutic development for small cell lung cancer
$1,062,000Charles M Rudin · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Magnetically Enhanced Diffusion for Intra-Arterial Treatment of Acute Ischemic Stroke
$1,061,579Martin Omid Akhavan · Pulse Therapeutics, Inc. · R44 · FY2022 · NS
Identification of novel MDR antimicrobials from insect-Streptomyces symbioses
$1,061,111Cameron Robert Currie · University Of Wisconsin-Madison · U19 · FY2021 · AI
A Patient-Centric Approach to Advance Functional Precision Oncology
$1,060,954Christopher J Kemp · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Hydrogel Particle-Based microRNA Profiling for Discovery and Cancer Diagnostics
$1,060,790Daniel Pregibon · Firefly Bioworks, Inc. · R44 · FY2011 · CA
Novel Therapies for Alcoholic Hepatitis
$1,060,741Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2014 · AA
Novel Therapies for Alcoholic Hepatitis
$1,060,741Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2015 · AA
Center for Computational Mass-Spectrometry
$1,060,209Pavel A Pevzner · University Of California, San Diego · P41 · FY2013 · GM
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,060,200Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,060,200Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2020 · CA
Inhibitors of protein-protein interactions
$1,060,173Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
DNA 3.0: Development of a novel, efficient and cost-effective enzymatic process for synthesis of DNA oligonucleotides
$1,059,968Helge Zieler · Primrose Bio, Inc. · R44 · FY2022 · HG
Targeting the Urgent Need for New Antibiotics against Gram-negative âSuperbugsâ
$1,059,804Jian Li · Monash University · R01 · FY2017 · AI